An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August ...
It is essential that one does not neglect these symptoms at initial stage in order to obtain optimal success of treatment. One has to meet a Urologist for proper assessment of their urinary symptoms.